4 TH Biennial Meeting OCTOBER 21-23, 2010 INML,I.P. – LEGAL MEDICINE NATIONAL INSTITUTE SOUTH BRANCH – LISBON – PORTUGAL Rosa H. de Gouveia or Rui Gonçalves.

Slides:

Advertisements

Similar presentations

The Olympics Games 2012.

Advertisements

POLYTECHNIC INSTITUTE OF LEIRIA Maria dos Anjos Dixe –

Prof Desmond Sheridan ESC mission To improve the quality of life of the European population by reducing the impact of cardiovascular disease.

Using a parallel corpus in translation practice and research Ana Frankenberg-Garcia

The Argentina Society of Hypertension has developed its "Annual Scholarship Program to Stimulate Research in Hypertension". This is a program of financial.

Eisenmenger Syndrome Seoul National University Hospital Department of Thoracic & Cardiovascular Surgery.

Cardiovascular Symposium 2014 Care at the Crossroads Saturday September 20, :00 a.m. – 1:30 p.m. Avalon Manor 3550 E. Lincoln Highway Merrillville,

1 Biomedical Sciences Public and Environmental Health Regenerative Medicine Translational Research.

4 TH Biennial Meeting OCTOBER 21-23, 2010 INML,I.P. – LEGAL MEDICINE NATIONAL INSTITUTE SOUTH BRANCH – LISBON – PORTUGAL Rosa H. de Gouveia or Rui Gonçalves.

Working with COMPARA an online parallel corpus of English and Portuguese fiction Ana Frankenberg-Garcia.

To reduce the burden of cardiovascular disease in Europe.

HISTORY OF MEDICAL BIOTECHNOLOGY CHANGES IN THE LAST 15 YEARS.

Hmmmm… … What is Cardiology What is Cardiology? Cardiologists are doctors specially trained in treating problems involved in the heart. For example,

Organs for research and education Matthew Bock. When are organs used for research? Only after they have been determined unsuitable for transplant.

OMICS Group Contact us at: OMICS Group International through its Open Access Initiative is committed to make genuine and.

Preliminary Program Wed. Sept 27 th 09: Pré-congress workshops Evening: City Hall Reception Thurs. Sept 28 th 09:00-11:00 Scientific Sessions:

Poster Title Author(s) Institution Poster Title Author(s) Institution INTRODUCTION HISTORY SIMSCON th South Indian Medical Students’ Conference,

Pathology: the heart of modern healthcare

Challenge and Innovation in Cardiovascular Therapeutics: 1st Annual BHF Centre Symposium Michael D. Schneider MD FMedSci Head, National Heart and Lung.

2 nd Annual Cardiovascular Symposium Dr. Jack Baker, Chairman, Department of Cardiovascular Services October 17, Confidential Not for Distribution.

The Structural Heart Disease Program your partners for advanced interventional cardiology Structural Heart Disease is a new branch of cardiology involving.

Facts about Pauls Stradins Clinical University Hospital Established in 1910 Great investments by professor Pauls Stradins (1896 – 1958) ‏ Leading multi-functional.

Circulatory Disorders. Coronary Artery Disease Plaque buildup in coronary arteries. Prevents the heart from receiving oxygen-rich blood. Causes/Risk Factors:

kvs1ed.ppt 1 Heart and Circulatory Failure Lectures from Pathological Physiology Dental Medicine Study materials from Pathological Physiology,

Confidential. This presentation is provided for the recipient only and cannot be reproduced or shared without Tennova Healthcare, Inc.’s express consent.

OMICS international Contact us at: OMICS International through its Open Access Initiative is committed to make genuine and.

Dr C Raghu Interventional Cardiologist

WELCOME TO THE 6 th CONGRESS OF ASPIRE Jakarta 8 th -10 th, 2016.

Cardiovascular System By: Patricia De La Rosa & Ana Luisa Freiburghaus.

European trial on reduction of cardiac events with perindopril in stable coronary artery disease Presented at European Society of Cardiology 2003 EUROPA.

Serviço de Cardiologia Hospital de Santa Maria Centro Hospitalar Lisboa Norte Subclinical focal fibrosis and abnormal strain in patients with sarcoidosis.

SPANISH ASSOCIATION OF NURSES IN CARDIOLOGY (SANC)

LIFE AS A MEDICAL STUDENT Abby Besch, MS1.  After the application  Choosing a school  The summer before you start  First Day!  Classes  Schedule.

Atrial Fibrillation: An old age problem PCCS Village Hotel 18 th May 2011.

M ax D elbrück L ecture Date:June 17th, 2008 Speaker: Kenneth R. Chien MGH Cardiovascular Research Center Boston, USA Title:Toward human models of human.

Date of download: 7/6/2016 Copyright © The American College of Cardiology. All rights reserved. From: Hypertrophic Cardiomyopathy in Adulthood Associated.

High heart rate: a cardiovascular risk factor? by Stéphane Cook, Mario Togni, Marcus C. Schaub, Peter Wenaweser, and Otto M. Hess EHJ Volume 27(20):

Mark Edwards New Cross Hospital Wolverhampton

Stepwise approach to assessing cardiac patient risk for noncardiac surgery. (Reproduced, with permission, from Fleisher LA et al. ACC/AHA 2007 Guidelines.

Stepwise approach to assessing cardiac patient risk for noncardiac surgery. (Reproduced, with permission, from Fleisher LA et al. ACC/AHA 2007 Guidelines.

Heterotopic heart transplantation: A direct pulmonary artery anastomosis technique José Pedro Da Silva, MD, Marcelo Matos Cascudo, MD, José Francisco.

The 7th Biennial Meeting

Welcome as young Colleagues to

April 7Th LIVE CASES April 7th – Friday morning PPH Congress Centre

Annual Scientific Meeting 2017: Updates on Liver Pathology

OMICS Journals are welcoming Submissions

CEO Report to the Hospital Authority Board Open Session

Patient populations by study group figure 10

Clinical practice in Crohn's disease in bordering regions of two countries: Different medical options, distinct surgical events Fernando Magro, Manuel.

Organs for research and education

Identifying exclusive patterns in unaligned sets of sequences

Clinical practice in Crohn's disease in bordering regions of two countries: Different medical options, distinct surgical events Fernando Magro, Manuel.

CSS Clinical Trial Launched: January 2018

Cardiac Cath NUR 422.

Know Your ABCs: Antiplatelet Therapy, Benefits/Bleeding, and Cardiac Surgery State of the Art: The Role of Antiplatelet Therapy in the Cardiac Surgical.

Pedro Ferreira Trancoso, DDM MSc Oral Med

Update in Cardiac and Thoracic Surgery

Death, target vessel revascularisation (TVR) and myocardial infarction (MI) with bioresorbable vascular scaffold (BVS) versus drug-eluting stent (DES)

SIGNIFY Trial design: Participants with stable coronary artery disease without clinical heart failure and resting heart rate >70 bpm were randomized to.

Y-SNPs genetic variation in the Caucasian population living in southern Portugal Sara Gaudêncio, Heloísa Afonso Costa, António Amorim, Teresa Ribeiro,

Gaetano Thiene, MD The Journal of Thoracic and Cardiovascular Surgery

Cavopulmonary anastomosis in staging toward fontan operation: pathologic substrates Annalisa Angelini, MD, Carla Frescura, MD, Giovanni Stellin, MD, Gaetano.

Publishers of Quality Research

Any and definite stent thrombosis (ST) and in-device late lumen loss (LLL) with bioresorbable vascular scaffold (BVS) versus drug-eluting stent (DES) in.

Death, target vessel revascularisation (TVR) and myocardial infarction (MI) with bioresorbable vascular scaffold (BVS) versus drug-eluting stent (DES)

Allelic frequencies of 15 autosomal STRs from two main population groups (Makua and Changana) in Mozambique Armando Cinturão Semo, Mónica Ramos Carvalho,

Clinical case report platform

Summary of STICH trial patients included in the analysis of 6 min walk distance. Reasons for non-inclusion at each follow-up time are given. CABG, coronary.

ประกาศกระทรวงอุตสาหกรรม ฉบับที่ 5292 (พ.ศ. 2562)

P2Y12 receptor inhibitor therapy for secondary prevention of patients with stable coronary artery disease. P2Y12 receptor inhibitor therapy for secondary.

Presentation transcript:

4 TH Biennial Meeting OCTOBER 21-23, 2010 INML,I.P. – LEGAL MEDICINE NATIONAL INSTITUTE SOUTH BRANCH – LISBON – PORTUGAL Rosa H. de Gouveia or Rui Gonçalves or Manuela Marques Rua Manuel Bento de Sousa, 3 – Lisboa Tel: Fax: e.mail(s): or SPAP, SPC-GEDMP AECVP President Ulrik Braandrup (DK) 21 ST OCTOBER (12h-16h) Registration (12h) Opening Ceremony (13h) R.H. de Gouveia (PT), U. Braandrup (DK), J. Costa Santos (PT) Basic Sciences & Cardiovascular Pathology (13.20h) Chairpersons: U. Braandrup (DK), A. Cidadão (PT) Stem Cells in Cardiovascular Diseases Nuno Cardim (PT) Therapy of Heart Failure: Regeneration vs Transplantation Annalisa Angelini (IT) Genetics of Sudden and Unexplained Death María Brión (SP) Coronary Artery Disease and Sudden Cardiac Death in the Young Gaetano Thiene (IT) Coffee-Break (14.30h) Valvular Pathology (14.45h) Chairpersons:Gaetano Thiene (IT), M.Abecasis (PT) Clinical Aspects and Diagnosis of Valvular Diseases Diogo Cavaco (PT) Valvular Diseases and Sudden Death Cristina Basso (IT) New Trends in Valvular Surgery Manuel Antunes (PT) Surgical Pathology Update in Valvular Disease Patrick Bruneval (FR) Board Meeting (16h) Board Dinner (19h) 22 ND OCTOBER (9h-20h) Cardiomyopathies (9h) Chairpersons: C. Aguiar (PT), U. Braandrup (DK) Clinical Presentation, Diagnosis and Treatment Hugo Madeira (PT) Pathology of Secondary Cardiomyopathies Ornella Leone (IT) Cardiac Transplantation in Secondary Cardiomyopathies Margaret Burke (UK) Portuguese Paramyloidosis: History, Pathology & Molecular Aspects Dulce Brito (PT) Coffee-Break (10.20h) Keynote-Lecture1 (10.35h) Chairperson: R.H. de Gouveia Interventional Cardiology in 2010 Ricardo Seabra-Gomes Free Communications1 (11.10h) Chairpersons: I. Fonseca (PT), I. Kholová (FIN) Lunch (12h) Drugs and the Heart (13h) Chairpersons: D.N. Vieira (PT), Paul Fornes (FR) Drug Therapy of Cardiovascular Diseases – Pros & Cons Jorge Ferreira (PT) Cardiac Side-Effects of Cancer Therapy Carlos Carvalho (PT) Cardiovascular Intoxication – How to Perform Toxicological Investigation? Mário João Dias (PT) Pathology of Cardiovascular Intoxication Rosa Henriques de Gouveia (PT) Cardiovascular Pathology in Cocaine Abusers – Spanish Experience Joaquin Lucena (SP) Coffee-Break (14.10h) Key-note Lecture2 (14.25h) Chairperson: Gaetano Thiene (IT) Henry the Navigator Rui Carita (PT) Free Communications2 (14.55h) Chairpersons: K. Survana (UK), E. Pinto (PT) Bussiness Meeting (16.15h) Congress Dinner (20h) 23 RD OCTOBER (9h-16.30h) Keynote Lecture3 (9h) Chairperson: Gaetano Thiene (IT) The Future of Cardiovascular Pathology J.P. Veinot (CAN) What is it? Session (9.30h) Chairpersons: P. Gallagher (UK), R. Anjos (PT) Coffee-Break (10.45h) Poster Session1 (11h) Chairpersons: M. Sheppard (UK), E. Pinto (PT), S. Ramos (PT) Lunch (12h) Neurological Vascular Pathology (13h) Chairpersons: A. v. der Wal (NL), C. Januário (PT) The Heart-Brain Axis João Queirós e Melo (PT) & Isabel Rocha (PT) Neuro-Oftalmological View João Costa (PT) Vascular Pathological Aspects Patrick Gallagher (UK) Surgical and Interventional Management A.J. Gonçalves Ferreira & Domingos Coiteiro (PT) Poster Session2 (14.10h) Chairpersons: K. Michaud (CH), L. Catarino (PT) Coffee-Break (15.10h) Prizes Award “Momentum” (15.25h) Free Communications – Ascenção Rebelo (PT) Posters – Francisco Henriques de Gouveia (PT) What is it? Session – Ulrik Braandrup (DK) Closing Ceremony (16h) Chairpersons: U. Braandrup (DK), R.H.de Gouveia (PT), D.N. Vieira (PT) PROGRAM